Literature DB >> 6584311

Serum C-reactive protein levels in the management of infection in acute leukaemia.

I D Starke, F C de Beer, J P Donnelly, D Catovsky, J M Goldman, D A Galton, M B Pepys.   

Abstract

C-reactive protein (CRP) was measured serially in 29 patients with acute leukaemia. Sixty-four febrile episodes (greater than or equal to 38 degrees C) occurred during 37 periods of neutropenia (less than 0.5 X 10(9)/l). In all of 41 microbiologically or clinically documented infections the maximum CRP level exceeded 30 mg/l, and in 25 it was greater than 100 mg/l. In no case in which the CRP level remained below 30 mg/l for 48 hr after the onset of fever was any clinical or microbiological evidence of infection obtained. The CRP level during documented infection began to fall 24-48 hr after appropriate treatment was begun. A CRP level above 30 mg/l in neutropenic patients was associated with early recurrence of fever if systemic antibiotics were discontinued. Graft-vs-host disease, without infection, did not result in high levels of CRP.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6584311     DOI: 10.1016/0277-5379(84)90076-2

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  9 in total

Review 1.  Tests for detecting and monitoring the acute phase response.

Authors:  J Stuart; J T Whicher
Journal:  Arch Dis Child       Date:  1988-02       Impact factor: 3.791

2.  C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients.

Authors:  P C Ligtenberg; I M Hoepelman; G A Oude Sogtoen; A W Dekker; I van der Tweel; M Rozenberg-Arska; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-01       Impact factor: 3.267

3.  An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.

Authors:  A Engel; E Mack; P Kern; W V Kern
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

4.  C-reactive protein as an indicator of infection in the immunosuppressed child.

Authors:  M Grønn; S H Slørdahl; S Skrede; S O Lie
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

5.  Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.

Authors:  D M Vigushin; M B Pepys; P N Hawkins
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  C-reactive protein during chemotherapy for acute leukemia with special reference to non-infective causes of fever.

Authors:  S Grützmeier; H von Schenck
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

7.  Serial study of C-reactive protein during fungal esophagitis and enterocolitis.

Authors:  I Kostiala; A A Kostiala; E Elonen
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

8.  Value of measurement of C-reactive protein in febrile patients with hematological malignancies.

Authors:  E Rintala; K Irjala; J Nikoskelainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

9.  Childhood social disadvantage, cardiometabolic risk, and chronic disease in adulthood.

Authors:  Amy L Non; Marissa Rewak; Ichiro Kawachi; Stephen E Gilman; Eric B Loucks; Allison A Appleton; Jorge C Román; Stephen L Buka; Laura D Kubzansky
Journal:  Am J Epidemiol       Date:  2014-06-26       Impact factor: 4.897

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.